Get the Stockscreener App
2.0701
2.80%
-0.0699
Nls Pharmaceutics Ltd stock is traded at $2.0701, with a volume of 40,807.
It is down -2.80% in the last 24 hours and down -15.10% over the past month.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
See More
Previous Close:
$2.14
Open:
$2.11
24h Volume:
40,807
Relative Volume:
0.19
Market Cap:
$7.48M
Revenue:
-
Net Income/Loss:
$-15.47M
P/E Ratio:
-4.1402
EPS:
-0.5
Net Cash Flow:
$-13.51M
1W Performance:
+0.97%
1M Performance:
-15.10%
6M Performance:
+38.67%
1Y Performance:
-60.70%
1-Day Range:
$2.0564
$2.19
1-Week Range:
$1.93
$2.24
52-Week Range:
$1.30
$5.95
Nls Pharmaceutics Ltd Stock (NLSP) Company Profile
Compare NLSP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NLSP
Nls Pharmaceutics Ltd
|
2.08 | 8.84M | 0 | -15.47M | -13.51M | -0.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
382.25 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.13 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
719.15 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
331.00 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Nls Pharmaceutics Ltd Stock (NLSP) Latest News
What’s next for NLS Pharmaceutics AG Equity Warrant stock priceWeekly Market Report & Verified Stock Trade Ideas - newser.com
Using economic indicators to assess NLS Pharmaceutics AG Equity Warrant potentialWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
Is NLS Pharmaceutics AG stock ready for a breakoutTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
Market reaction to NLS Pharmaceutics AG Equity Warrant’s recent newsJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com
Custom strategy builders for tracking NLS Pharmaceutics AGMarket Performance Report & AI Enhanced Market Trend Forecasts - newser.com
Rally Mode: Does NLS Pharmaceutics AG stock benefit from AI growthPrice Action & Low Risk Growth Stock Ideas - خودرو بانک
Visual trend scoring systems applied to NLS Pharmaceutics AG Equity WarrantJuly 2025 Big Picture & Smart Allocation Stock Tips - newser.com
What data driven models say about NLS Pharmaceutics AG Equity Warrant’s futureJuly 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com
What the charts say about NLS Pharmaceutics AG Equity Warrant todayNew Guidance & Free Accurate Trade Setup Notifications - newser.com
How moving averages guide NLS Pharmaceutics AG tradingTreasury Yields & High Accuracy Trade Signal Alerts - newser.com
Chart based exit strategy for NLS Pharmaceutics AGProfit Target & Intraday High Probability Setup Alerts - newser.com
Is NLS Pharmaceutics AG stock reversal real or fakeQuarterly Portfolio Summary & Smart Swing Trading Alerts - newser.com
What to expect from NLS Pharmaceutics AG Equity Warrant in the next 30 days2025 Price Targets & Low Drawdown Investment Strategies - newser.com
How to track smart money flows in NLS Pharmaceutics AG Equity WarrantPortfolio Growth Summary & Real-Time Sentiment Analysis - newser.com
Bond Watch: Is NLS Pharmaceutics AG stock a buy or sellTrade Analysis Report & Intraday High Probability Alerts - خودرو بانک
When is the best time to exit NLS Pharmaceutics AG2025 Performance Recap & High Accuracy Trade Alerts - newser.com
What technical models suggest about NLS Pharmaceutics AG Equity Warrant’s comeback2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Evaluating NLS Pharmaceutics AG with trendline analysis2025 Key Lessons & Weekly Top Gainers Trade List - newser.com
NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation - TipRanks
Using AI based signals to follow NLS Pharmaceutics AG Equity WarrantWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Sell Signal: Is NLS Pharmaceutics AG subject to activist investor interestJuly 2025 Opening Moves & Low Volatility Stock Suggestions - خودرو بانک
How to interpret RSI for NLS Pharmaceutics AG stock2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com
Can volume confirm reversal in NLS Pharmaceutics AGJuly 2025 Retail & Risk Managed Investment Signals - newser.com
Will NLS Pharmaceutics AG see short term momentumQuarterly Market Review & Momentum Based Trading Signals - newser.com
AI Stocks: Whats the outlook for NLS Pharmaceutics AGs sector2025 Macro Impact & Fast Exit Strategy with Risk Control - خودرو بانک
NLS Pharmaceutics AG Equity Warrant recovery potential after sell offProduct Launch & High Return Stock Watch Alerts - newser.com
EV Market: Is NLS Pharmaceutics AG subject to activist investor interestJuly 2025 Levels & Reliable Intraday Trade Plans - خودرو بانک
Will NLS Pharmaceutics AG Equity Warrant see short term momentumWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com
Technical signs of recovery in NLS Pharmaceutics AG2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Nls Pharmaceutics Ltd Stock (NLSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):